BMRN vs OLED · P/E 40, rev $2.85B vs P/E 33, rev $647.7M
Biomarin Pharmaceutical Inc (BMRN) versus Universal Display (OLED) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Universal Display (OLED) is a electronic components company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported OLED revenue for 2024-12-31 was $647.7M. Net income was $222.1M. Revenue was up 12.4% from 2023-12-31 to 2024-12-31. OLED currently screens at market cap $7.49B and trailing P/E 32.8.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. OLED currently screens at market cap $7.49B and trailing P/E 32.8.
Not investment advice. Open the BMRN and OLED stock pages for the full models.
Not investment advice.